IMI vs Intuitive Surgical Which Should You Buy?
IMI (Integrated Medical Systems International) is a leading provider of surgical instruments and systems, while Intuitive Surgical is a pioneer in robotic-assisted surgery technology. Both companies operate in the healthcare sector, with IMI focusing on traditional surgical tools and Intuitive Surgical on cutting-edge robotic solutions. Investors looking to compare the two stocks may consider factors such as revenue growth, market share, technological advancements, and potential for future growth in the rapidly evolving healthcare industry.
IMI or Intuitive Surgical?
When comparing IMI and Intuitive Surgical, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between IMI and Intuitive Surgical.
Dividend Investors:
Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company.
IMI has a dividend yield of 1.66%, while Intuitive Surgical has a dividend yield of -%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. IMI reports a 5-year dividend growth of -7.81% year and a payout ratio of 29.10%. On the other hand, Intuitive Surgical reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.36%.
Value Investors:
Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with IMI P/E ratio at 18.17 and Intuitive Surgical's P/E ratio at 84.98. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. IMI P/B ratio is 4.21 while Intuitive Surgical's P/B ratio is 12.23.
Growth Investors:
Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, IMI has seen a 5-year revenue growth of 0.20%, while Intuitive Surgical's is 0.86%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with IMI's ROE at 23.85% and Intuitive Surgical's ROE at 15.59%.
Retail Investors:
Retail investors often consider stock affordability and company familiarity. For example, day low prices are £1753.00 for IMI and $534.57 for Intuitive Surgical. Over the past year, IMI's prices ranged from £1512.00 to £1911.00, with a yearly change of 26.39%. Intuitive Surgical's prices fluctuated between $281.12 and $542.59, with a yearly change of 93.01%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.